Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Drug Interactions »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Industry (trends) < Drug Interactions < Drug Interactions (physiology)  Facettes :

List of bibliographic references indexed by Drug Interactions

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000932 (2014) Michel Panisset [Canada] ; Jack J. Chen ; Sean H. Rhyee ; Jill Conner ; Julie MathenaSerotonin toxicity association with concomitant antidepressants and rasagiline treatment: retrospective study (STACCATO).
000A55 (2014) Jocelyn M. Madeira [Canada] ; Ekta Bajwa [Canada] ; Maegan J. Stuart [Canada] ; Sadayuki Hashioka [Japon] ; Andis Klegeris [Canada]Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst.
001191 (2012) Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. BrotchieL-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
002285 (2008) Andis Klegeris [Canada] ; Jane Li [États-Unis] ; Theo K. Bammler [États-Unis] ; Jinghua Jin [États-Unis] ; David Zhu [États-Unis] ; Daniel T. Kashima [États-Unis] ; Sheng Pan [États-Unis] ; Sadayuki Hashioka [Canada] ; John Maguire [Canada] ; Patrick L. Mcgeer [Canada] ; Jing Zhang [États-Unis]Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP‐1 cell neurotoxicity
002707 (2006) Christina R. Zamzow [Canada] ; Ratna Bose ; Fiona E. ParkinsonThe effect of acidosis on adenosine release from cultured rat forebrain neurons.
002998 (2005) Fiona E. Parkinson [Canada] ; Wei Xiong ; Christina R. ZamzowAstrocytes and neurons: different roles in regulating adenosine levels.
002B88 (2004) Abdallah Hadj Tahar [Canada] ; Laurent Grégoire ; Aurélie Darré ; Nancy Bélanger ; Leonard Meltzer ; Paul J. BédardEffect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.
002D98 (2003) A Jon Stoessl [Canada]Agonizing over dopaminergic replacement therapy--lessons from animal models of Parkinson's disease.
003619 (1999) J A Barone [États-Unis]Domperidone: a peripherally acting dopamine2-receptor antagonist.
004827 (1991) B. Gomez-Mancilla [Canada] ; P. J. BedardEffect of D1 and D2 agonists and antagonists on dyskinesia produced by L-DOPA in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys
004985 (1990) N. R. C. Campbell ; D. Rankine ; A. E. Goodridge ; B. B. Hasinoff ; M. KaraSinemet-ferrous sulphate interaction in patients with Parkinson's disease
005656 (????) David K. Simon [Singapour] ; Cai Wu ; Barbara C. Tilley ; Anne-Marie Wills ; Michael J. Aminoff ; Jacquelyn Bainbridge ; Robert A. Hauser ; Jay S. Schneider ; Saloni Sharma ; Carlos Singer ; Caroline M. Tanner ; Daniel Truong ; Pei Shieen WongCaffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Drug Interactions" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Drug Interactions" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Drug Interactions
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022